Bayer has won U.S. Food and Drug Administration priority review for its application seeking expanded approval of its kidney-disease drug Kerendia in certain people with heart failure.
Artificial Intelligence (AI) in medicine is crucial to understanding how the human body works. It is not only helping doctors ...